Patents Assigned to Noro Nordisk A/S
  • Patent number: 6537252
    Abstract: An automatic needle insertion device for a pen shaped syringe comprising a cartridge holder (2) wherein a cartridge with a drug can be accommodated, and a dose setting and injection part (1) by which a wanted dose may be set an subsequently pressed out from the cartridge by pressing a button (12) projecting from the dose setting and injection part (1). The device comprises a mainly tubular housing (31) in which a tubular pen holder (22) in which a pen can be mounted can be axially displaced in a proximal direction to cock a spring (30) which can thereafter be released to drive the pen holder (22) with the pen a set distance in a distal direction.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: March 25, 2003
    Assignee: Noro Nordisk A/S
    Inventor: Niels-Aage Hansen
  • Patent number: 6524280
    Abstract: Described is a dose setting limiter for medical injectors of the type having a housing accommodating an ampoule-containing medicine sufficient for a number of dosed injections, a rotary dose setting knob, which is rotational relative to the housing and by which doses may be set by rotating the dose setting knob and an injection button which, when activated, administers the set dose. The dose setting limiter includes a stationary first part connected to the housing, and a second part fitted over the rotary dose setting knob, the second part being able to rotate together with the dose setting knob when setting up a dose and the second part being rotational relative to the first part. A third part is placed between the first part and the second part, the third part having means cooperating with means on the second part for limiting the dose setting.
    Type: Grant
    Filed: January 24, 2001
    Date of Patent: February 25, 2003
    Assignee: Noro Nordisk A/S
    Inventors: Steffen Hansen, Peter Christian Klitgaard
  • Patent number: 6503949
    Abstract: Disclosed is a novel class of compounds of formula (I) wherein V, A, Y, Z, R1, E, X and D are as defined in the specification. These compounds act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor, the compounds are suitable for treating or preventing glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: January 7, 2003
    Assignee: Noro Nordisk A/S
    Inventors: Jesper Lau, Peter Madsen, Christian Sams, Carsten Behrens, Josef Vagner, Inge Thøger Christensen, Behrend Frederik Lundt, Ulla Grove Sidelmann, Henning Thøgersen, Anthony L. Ling, Michael Bruno Plewe, Larry Kenneth Truesdale, Shenghua Shi
  • Patent number: 5376288
    Abstract: The detergent additive granulate is a coated co-granulate containing at least one enzyme and at least one photobleaching agent. If a detergent, a component of which is such detergent additive granulate, is used for laundering, the photobleaching agent will not tend to adhere selectively to the laundry during the initial washing process.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: December 27, 1994
    Assignee: Noro Nordisk A/S
    Inventors: Per Falholt, Erik K. Markussen
  • Patent number: 5273898
    Abstract: Thermally stable, positionally non-specific lipases native to Candida species of C. antartica, C. tsukubaensis, C. auriculariae, C. humicola, and C. foliarum, are isolated. The lipase of C. antarctica, is preferred. Two lipase activities are elaborated by C. antarctica. One lipase fraction being 43 kD in molecular weight, and of an isoelectric point of about 8.0 and has excellent thermostability. The other fraction being 33 kD in molecular weight and of an isoelectric point of about 6.0 and has high retention of residual activity at pH 10.
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: December 28, 1993
    Assignee: Noro Nordisk A/S
    Inventor: Michiyo Ishii